What is the Bliss GVS Pharma Ltd share price today?

The share price of NSE:BLISSGVS-BE on 01 Oct 2026 (as of 15:03:13 IST) is ₹680.4.

What is the NSE:BLISSGVS-BE 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:BLISSGVS-BE 52 week high low range shows a high of ₹739.9 and a low of ₹118.

What is the Bliss GVS Pharma Ltd market cap?

As on 01 Oct 2026, Bliss GVS Pharma Ltd market cap is ₹73936900000.

What is the shareholding pattern of Bliss GVS Pharma Ltd Stock?

The shareholding pattern of Bliss GVS Pharma Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 35.01% Foreign Institutional Investors (FII): 8.07% Domestic Institutional Investors (DII): 9.06% Mutual Funds: 0.26% Retail & Others: 47.6% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Bliss GVS Pharma Ltd?

The Price-to-Earnings (PE) ratio of Bliss GVS Pharma Ltd is 54.2903, and the Price-to-Book (PB) ratio is 1.9304, as on 01 Oct 2026.

Bliss GVS Pharma Share Price

692.00+27.20 (+4.09%)

+357.13% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

+4.09%

1 Week

+1.23%

1 Month

+3.13%

3 Month

+34.91%

6 Month

+172.37%

YTD

+323.53%

1 Year

+357.13%

5 Year

+527.95%

10 Year

+382.23%

Max

+1549.58%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

660.00

650.75

443.00

248.50

118.00

High

697.00

697.90

739.90

About

Bliss GVS Pharma Limited is a fast-growing Pharmaceutical Company with a proven track record of developing manufacturing and marketing high quality pharmaceutical formulations at affordable prices for the global market. Read more

Pharmaceuticals & Drugs

Smallcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

ZYDUSLIFENSE

CIPLANSE

LAURUSLABSNSE

MANKINDNSE

DRREDDYNSE

AUROPHARMANSE

LUPINNSE

BLISSGVS-BENSE

LTP

1W Low

1W High

Market cap (₹)

1789.5-11.5 (-0.64%)

1768

1802.90

4,27,562Cr

9360+111 (1.20%)

9113.50

9379.50

2,44,572Cr

4761.7-5.6 (-0.12%)

4702.50

4795

1,80,871Cr

1151.4+5.7 (0.50%)

1128.10

1161.80

1,13,566Cr

1337.5-6.5 (-0.48%)

1321

1337.70

1,07,770Cr

2014.4+30.4 (1.53%)

1955.10

2023.30

1,06,117Cr

2499.5-35.5 (-1.40%)

2464.50

2539.30

1,02,433Cr

1210.9+4.7 (0.39%)

1189

1212.50

1,00,829Cr

1688.7+11.9 (0.71%)

1663.10

1696

96,088Cr

2015.4-15.8 (-0.78%)

1996.30

2029

91,915Cr

692+8.4 (1.23%)

660

697.90

7,023Cr

Bliss GVS Pharma Share Price

692.00+27.20 (+4.09%)

+357.13% past 1 Year

Financial overview

Compounded Sales Growth

10 years5%

5 years10%

3 years7%

Last year14%

Compounded Profit Growth

10 years5%

5 years14%

3 years22%

Last year49%

Stock Price CAGR

10 years17%

5 years43%

3 years96%

1 year339%

Return on Equity

10 years13%

5 years8%

3 years10%

Last year12%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
5%	10%	7%	14%
5%	14%	22%	49%
17%	43%	96%	339%
13%	8%	10%	12%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

ZYDUSLIFE

CIPLA

LAURUSLABS

MANKIND

DRREDDY

AUROPHARMA

LUPIN

BLISSGVS-BE

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,789.5	₹427562 Cr	35.35	12.07	62.82	₹11479 Cr
9,360	₹244572 Cr	83.61	34.04	128.41	₹2568 Cr
4,761.7	₹180871 Cr	82.93	16.72	97.06	₹2163 Cr
1,151.4	₹113566 Cr	25.16	9.42	62.53	₹5040 Cr
1,337.5	₹107770 Cr	31.97	9.77	57.87	₹3879 Cr
2,014.4	₹106117 Cr	97.06	6.8	29.25	₹889 Cr
2,499.5	₹102433 Cr	50.15	13.75	71.08	₹1913 Cr
1,210.9	₹100829 Cr	31.29	5.32	63.99	₹4196 Cr
1,688.7	₹96088 Cr	25.88	17.95	96.84	₹3505 Cr
2,015.4	₹91915 Cr	16.62	30.95	154.35	₹5333 Cr
692	₹7023 Cr	51.57	4.72	16.12	₹129 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021	Mar 2021	Dec 2020	Sep 2020	Jun 2020	Mar 2020	Dec 2019	Sep 2019	Jun 2019	Mar 2019	Dec 2018	Sep 2018	Jun 2018	Mar 2018	Dec 2017	Sep 2017	Jun 2017	Mar 2017	Dec 2016	Sep 2016	Jun 2016	Mar 2016	Dec 2015	Sep 2015	Jun 2015
₹286 Cr	₹257 Cr	₹218 Cr	₹244 Cr	₹207 Cr	₹198 Cr	₹210 Cr	₹218 Cr	₹184 Cr	₹198 Cr	₹201 Cr	₹212 Cr	₹160 Cr	₹185 Cr	₹206 Cr	₹172 Cr	₹189 Cr	₹167 Cr	₹216 Cr	₹196 Cr	₹168 Cr	₹132 Cr	₹164 Cr	₹130 Cr	₹130 Cr	₹120 Cr	₹148 Cr	₹210 Cr	₹212 Cr	₹244 Cr	₹220 Cr	₹228 Cr	₹205 Cr	₹167 Cr	₹196 Cr	₹227 Cr	₹226 Cr	₹258 Cr	₹234 Cr	₹169 Cr	₹141 Cr	₹144 Cr	₹132 Cr	₹176 Cr	₹95 Cr
₹10 Cr	₹11 Cr	₹18 Cr	₹20 Cr	₹35 Cr	₹12 Cr	₹15 Cr	₹7 Cr	₹4 Cr	₹6 Cr	₹5 Cr	₹13 Cr	₹5 Cr	₹3 Cr	₹6 Cr	₹2 Cr	₹7 Cr	₹12 Cr	₹6 Cr	₹5 Cr	₹8 Cr	₹6 Cr	₹4 Cr	₹7 Cr	₹7 Cr	₹19 Cr	₹6 Cr	₹13 Cr	₹2 Cr	₹3 Cr	-₹4 Cr	₹25 Cr	₹14 Cr	₹6 Cr	₹2 Cr	₹15 Cr	₹4 Cr	-₹7 Cr	₹8 Cr	₹3 Cr	₹8 Cr	₹4 Cr	₹6 Cr	₹8 Cr	₹6 Cr
₹295 Cr	₹268 Cr	₹237 Cr	₹265 Cr	₹243 Cr	₹210 Cr	₹226 Cr	₹224 Cr	₹188 Cr	₹204 Cr	₹206 Cr	₹224 Cr	₹165 Cr	₹188 Cr	₹211 Cr	₹175 Cr	₹196 Cr	₹179 Cr	₹222 Cr	₹201 Cr	₹176 Cr	₹138 Cr	₹168 Cr	₹137 Cr	₹137 Cr	₹138 Cr	₹153 Cr	₹223 Cr	₹214 Cr	₹247 Cr	₹217 Cr	₹253 Cr	₹219 Cr	₹173 Cr	₹198 Cr	₹242 Cr	₹229 Cr	₹252 Cr	₹242 Cr	₹172 Cr	₹150 Cr	₹148 Cr	₹139 Cr	₹184 Cr	₹101 Cr
₹219 Cr	₹221 Cr	₹192 Cr	₹221 Cr	₹174 Cr	₹185 Cr	₹188 Cr	₹185 Cr	₹156 Cr	₹177 Cr	₹164 Cr	₹164 Cr	₹141 Cr	₹183 Cr	₹163 Cr	₹152 Cr	₹154 Cr	₹151 Cr	₹187 Cr	₹171 Cr	₹138 Cr	₹119 Cr	₹130 Cr	₹114 Cr	₹114 Cr	₹107 Cr	₹118 Cr	₹188 Cr	₹165 Cr	₹215 Cr	₹179 Cr	₹189 Cr	₹167 Cr	₹134 Cr	₹154 Cr	₹184 Cr	₹167 Cr	₹183 Cr	₹200 Cr	₹131 Cr	₹105 Cr	₹97 Cr	₹106 Cr	₹138 Cr	₹63 Cr
₹86 Cr	₹56 Cr	₹53 Cr	₹52 Cr	₹77 Cr	₹33 Cr	₹45 Cr	₹47 Cr	₹38 Cr	₹34 Cr	₹49 Cr	₹67 Cr	₹29 Cr	₹9 Cr	₹53 Cr	₹27 Cr	₹46 Cr	₹32 Cr	₹40 Cr	₹35 Cr	₹42 Cr	₹23 Cr	₹42 Cr	₹27 Cr	₹27 Cr	₹35 Cr	₹38 Cr	₹38 Cr	₹51 Cr	₹35 Cr	₹40 Cr	₹66 Cr	₹55 Cr	₹43 Cr	₹50 Cr	₹63 Cr	₹68 Cr	₹69 Cr	₹53 Cr	₹45 Cr	₹48 Cr	₹52 Cr	₹35 Cr	₹51 Cr	₹41 Cr
₹58 L	₹2 Cr	₹1 Cr	₹3 Cr	₹5 Cr	₹2 Cr	₹1 Cr	₹4 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹1 Cr	₹5 Cr	₹1 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹68 L	₹1 Cr	₹2 Cr	₹94 L	₹2 Cr	₹2 Cr	₹5 Cr	₹1 Cr	₹1 Cr	₹89 L	₹93 L	₹96 L	₹1 Cr	₹1 Cr	₹5 Cr	₹5 Cr	₹6 Cr	₹6 Cr	₹8 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹7 Cr	₹2 Cr	₹5 Cr	₹5 Cr
₹75 Cr	₹45 Cr	₹41 Cr	₹41 Cr	₹63 Cr	₹23 Cr	₹36 Cr	₹36 Cr	₹30 Cr	-₹4 Cr	₹40 Cr	₹59 Cr	₹22 Cr	-₹75 L	₹47 Cr	₹20 Cr	₹39 Cr	₹26 Cr	-₹39 Cr	₹30 Cr	₹37 Cr	₹17 Cr	₹37 Cr	₹20 Cr	₹20 Cr	₹13 Cr	₹34 Cr	₹34 Cr	₹47 Cr	₹32 Cr	₹36 Cr	₹63 Cr	₹51 Cr	-₹1 Cr	₹39 Cr	₹52 Cr	₹56 Cr	₹60 Cr	₹38 Cr	₹36 Cr	₹41 Cr	₹43 Cr	₹31 Cr	₹41 Cr	₹33 Cr
₹51 Cr	₹37 Cr	₹25 Cr	₹29 Cr	₹44 Cr	₹17 Cr	₹26 Cr	₹26 Cr	₹22 Cr	-₹5 Cr	₹29 Cr	₹43 Cr	₹14 Cr	₹3 Cr	₹30 Cr	₹16 Cr	₹27 Cr	₹23 Cr	-₹49 Cr	₹22 Cr	₹26 Cr	₹8 Cr	₹28 Cr	₹17 Cr	₹17 Cr	₹6 Cr	₹25 Cr	₹31 Cr	₹33 Cr	₹19 Cr	₹27 Cr	₹42 Cr	₹39 Cr	-₹14 Cr	₹26 Cr	₹39 Cr	₹37 Cr	₹43 Cr	₹22 Cr	₹21 Cr	₹28 Cr	₹29 Cr	₹23 Cr	₹28 Cr	₹20 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Miscellaneous Expenses not written off

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹11 Cr	₹11 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr	₹10 Cr
₹12 Cr	₹6 Cr	₹8 Cr	₹9 Cr	₹10 Cr	₹10 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹1171 Cr	₹1034 Cr	₹949 Cr	₹865 Cr	₹798 Cr	₹788 Cr	₹725 Cr	₹636 Cr	₹526 Cr	₹476 Cr	₹402 Cr	₹327 Cr	₹277 Cr	₹248 Cr	₹200 Cr	₹156 Cr
₹1171 Cr	₹1034 Cr	₹949 Cr	₹865 Cr	₹798 Cr	₹788 Cr	₹725 Cr	₹636 Cr	₹526 Cr	₹476 Cr	₹402 Cr	₹327 Cr	₹277 Cr	₹248 Cr	₹200 Cr	₹156 Cr
₹1193 Cr	₹1050 Cr	₹967 Cr	₹884 Cr	₹819 Cr	₹808 Cr	₹736 Cr	₹646 Cr	₹536 Cr	₹487 Cr	₹413 Cr	₹337 Cr	₹287 Cr	₹258 Cr	₹211 Cr	₹167 Cr
₹39 Cr	₹41 Cr	₹36 Cr	₹34 Cr	₹28 Cr	₹20 Cr	₹15 Cr	₹14 Cr	₹11 Cr	₹66 Cr	₹33 Cr	₹15 Cr	₹10 Cr	₹14 Cr	₹49,000	₹0
₹0	₹20 Cr	₹36 Cr	₹41 Cr	₹23 Cr	₹33 Cr	₹37 Cr	₹33 Cr	₹6 Cr	₹26 Cr	₹30 Cr	₹55 Cr	₹79 Cr	₹90 Cr	₹38 Cr	₹4 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹9 Cr	₹2 Cr	₹9 Cr	₹1 Cr	₹0	₹0
-₹16 Cr	₹30 L	₹4 Cr	-₹3 Cr	₹1 Cr	₹8 Cr	₹4 Cr	₹4 Cr	₹5 Cr	₹5 Cr	₹9 Cr	₹9 Cr	₹7 Cr	₹5 Cr	₹1 Cr	-₹37 L
₹22 Cr	₹13 Cr	₹9 Cr	₹3 Cr	₹4 Cr	₹2 Cr	₹3 Cr	₹13 L	₹0	₹40,000	₹0	₹0	₹0	₹0	₹0	₹0
₹3 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹1 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹1 Cr	₹1 Cr	₹74 L	₹51 L	₹58 L
₹9 Cr	₹37 Cr	₹51 Cr	₹43 Cr	₹29 Cr	₹45 Cr	₹46 Cr	₹38 Cr	₹13 Cr	₹33 Cr	₹50 Cr	₹68 Cr	₹96 Cr	₹97 Cr	₹39 Cr	₹4 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹104 Cr	₹71 Cr	₹61 Cr	₹86 Cr	₹93 Cr	₹74 Cr	₹90 Cr	₹79 Cr	₹58 Cr	₹98 Cr	₹108 Cr	₹80 Cr	₹82 Cr	₹118 Cr	₹40 Cr	₹31 Cr
₹94 Cr	₹73 Cr	₹62 Cr	₹58 Cr	₹68 Cr	₹54 Cr	₹57 Cr	₹50 Cr	₹124 Cr	₹100 Cr	₹53 Cr	₹70 Cr	₹42 Cr	₹24 Cr	₹6 Cr	₹4 Cr
₹3 Cr	₹23 Cr	₹32 Cr	₹46 Cr	₹61 Cr	₹65 Cr	₹66 Cr	₹64 Cr	₹106 Cr	₹187 Cr	₹62 Cr	₹61 Cr	₹57 Cr	₹45 Cr	₹6 Cr	₹3 Cr
₹35 Cr	₹4 Cr	₹2 Cr	₹3 Cr	₹12 Cr	₹11 Cr	₹17 Cr	₹14 Cr	₹11 Cr	₹51 Cr	₹156 Cr	₹31 Cr	₹126 Cr	₹14 Cr	₹8 Cr	₹4 Cr
₹236 Cr	₹172 Cr	₹157 Cr	₹193 Cr	₹233 Cr	₹204 Cr	₹231 Cr	₹207 Cr	₹299 Cr	₹437 Cr	₹379 Cr	₹243 Cr	₹308 Cr	₹202 Cr	₹60 Cr	₹43 Cr
₹1476 Cr	₹1301 Cr	₹1212 Cr	₹1154 Cr	₹1109 Cr	₹1077 Cr	₹1027 Cr	₹905 Cr	₹860 Cr	₹1023 Cr	₹874 Cr	₹662 Cr	₹700 Cr	₹571 Cr	₹310 Cr	₹213 Cr
₹11 Cr	₹5 Cr	₹57 Cr	₹12 Cr	₹23 Cr	₹30 Cr	₹14 Cr	₹2 Cr	₹4 Cr	₹44 Cr	₹30 Cr	₹40 Cr	₹48 Cr	₹44 Cr	₹51 Cr	₹12 Cr
₹3 Cr	₹71 Cr	₹88 Cr	₹98 Cr	₹105 Cr	₹119 Cr	₹121 Cr	₹102 Cr	₹118 Cr	₹225 Cr	₹132 Cr	₹160 Cr	₹173 Cr	₹147 Cr	₹45 Cr	₹8 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹607 Cr	₹531 Cr	₹468 Cr	₹459 Cr	₹343 Cr	₹285 Cr	₹276 Cr	₹170 Cr	₹157 Cr	₹327 Cr	₹301 Cr	₹294 Cr	₹262 Cr	₹206 Cr	₹64 Cr	₹41 Cr
₹149 Cr	₹126 Cr	₹98 Cr	₹81 Cr	₹63 Cr	₹51 Cr	₹35 Cr	₹25 Cr	₹21 Cr	₹23 Cr	₹75 Cr	₹59 Cr	₹49 Cr	₹38 Cr	₹24 Cr	₹21 Cr
₹459 Cr	₹405 Cr	₹369 Cr	₹378 Cr	₹281 Cr	₹234 Cr	₹241 Cr	₹145 Cr	₹136 Cr	₹304 Cr	₹225 Cr	₹234 Cr	₹213 Cr	₹168 Cr	₹40 Cr	₹20 Cr
₹6 Cr	₹21 Cr	₹8 Cr	₹3 Cr	₹22 Cr	₹2 Cr	₹0	₹47 Cr	₹47 L	₹4 Cr	₹9 Cr	₹0	₹4 Cr	₹65 L	₹6 Cr	₹8 Cr
₹4 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹2 Cr	₹1 L	₹72 L	₹72 L	₹6 Cr	₹1 Cr	₹11 L	₹1 L	₹1 L	₹1 L	₹1,000	₹1,000
₹4 Cr	₹4 Cr	₹4 Cr	₹3 Cr	₹2 Cr	₹1 L	₹72 L	₹72 L	₹6 Cr	₹1 Cr	₹11 L	₹1 L	₹1 L	₹1 L	₹1,000	₹1,000
₹30 Cr	₹20 Cr	₹15 Cr	₹18 Cr	₹24 Cr	₹13 Cr	₹15 Cr	₹19 Cr	₹27 Cr	₹11 Cr	₹57 Cr	₹10 Cr	₹12 Cr	₹51 Cr	₹53 Cr	₹29 Cr
₹31 Cr	₹27 Cr	₹5 Cr	₹54 Cr	₹1 Cr	₹62 Cr	₹1 Cr	₹33 L	₹29 L	₹137 Cr	₹0	₹0	₹0	₹0	₹0	₹0
₹530 Cr	₹477 Cr	₹401 Cr	₹456 Cr	₹332 Cr	₹312 Cr	₹257 Cr	₹211 Cr	₹170 Cr	₹457 Cr	₹291 Cr	₹245 Cr	₹230 Cr	₹220 Cr	₹100 Cr	₹57 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹1 Cr	₹0	₹56 L	₹5 Cr	₹0	₹0	₹0	₹0	₹0	₹1,000	₹0	₹0	₹0	₹0	₹80 L	₹0
₹151 Cr	₹126 Cr	₹118 Cr	₹103 Cr	₹124 Cr	₹99 Cr	₹74 Cr	₹77 Cr	₹59 Cr	₹49 Cr	₹39 Cr	₹34 Cr	₹33 Cr	₹33 Cr	₹13 Cr	₹12 Cr
₹517 Cr	₹439 Cr	₹404 Cr	₹385 Cr	₹393 Cr	₹464 Cr	₹548 Cr	₹461 Cr	₹298 Cr	₹254 Cr	₹301 Cr	₹247 Cr	₹215 Cr	₹245 Cr	₹129 Cr	₹120 Cr
₹167 Cr	₹213 Cr	₹216 Cr	₹103 Cr	₹178 Cr	₹145 Cr	₹103 Cr	₹107 Cr	₹89 Cr	₹151 Cr	₹78 Cr	₹57 Cr	₹80 Cr	₹50 Cr	₹58 Cr	₹18 Cr
₹14 Cr	₹15 Cr	₹17 Cr	₹7 Cr	₹14 Cr	₹18 Cr	₹16 Cr	₹26 Cr	₹97 Cr	₹33 Cr	₹15 Cr	₹18 Cr	₹11 Cr	₹12 Cr	₹4 Cr	₹5 Cr
₹96 Cr	₹24 Cr	₹55 Cr	₹95 Cr	₹69 Cr	₹40 Cr	₹28 Cr	₹23 Cr	₹146 Cr	₹78 Cr	₹150 Cr	₹61 Cr	₹130 Cr	₹9 Cr	₹5 Cr	₹3 Cr
₹946 Cr	₹817 Cr	₹811 Cr	₹697 Cr	₹777 Cr	₹765 Cr	₹770 Cr	₹693 Cr	₹690 Cr	₹566 Cr	₹583 Cr	₹417 Cr	₹469 Cr	₹349 Cr	₹210 Cr	₹157 Cr
₹711 Cr	₹644 Cr	₹653 Cr	₹504 Cr	₹544 Cr	₹562 Cr	₹539 Cr	₹486 Cr	₹390 Cr	₹129 Cr	₹204 Cr	₹174 Cr	₹162 Cr	₹147 Cr	₹150 Cr	₹114 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹43 L	₹1 Cr	₹2 Cr	₹0	₹0
₹1476 Cr	₹1301 Cr	₹1212 Cr	₹1154 Cr	₹1109 Cr	₹1077 Cr	₹1027 Cr	₹905 Cr	₹860 Cr	₹1023 Cr	₹874 Cr	₹662 Cr	₹700 Cr	₹571 Cr	₹310 Cr	₹213 Cr
₹112	₹99	₹92	₹84	₹78	₹77	₹71	₹63	₹52	₹47	₹40	₹33	₹28	₹25	₹20	₹16
₹112	₹99	₹92	₹84	₹78	₹77	₹71	₹63	₹52	₹47	₹40	₹33	₹28	₹25	₹20	₹16

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011
₹190 Cr	₹126 Cr	₹146 Cr	₹106 Cr	₹128 Cr	₹104 Cr	₹129 Cr	₹182 Cr	₹179 Cr	₹175 Cr	₹148 Cr	₹96 Cr	₹71 Cr	₹109 Cr	₹79 Cr	₹0
₹96 Cr	₹71 Cr	₹38 Cr	₹58 Cr	-₹32 Cr	₹46 Cr	₹27 Cr	-₹11 Cr	₹18 Cr	₹36 Cr	₹18 Cr	₹17 Cr	₹24 Cr	₹10 Cr	₹5 Cr	₹0
-₹104 Cr	-₹51 Cr	-₹47 Cr	-₹85 Cr	₹73 Cr	-₹58 Cr	-₹70 Cr	-₹183 Cr	-₹141 Cr	₹113 Cr	-₹8 Cr	-₹67 Cr	-₹19 Cr	-₹74 Cr	-₹38 Cr	₹0
₹181 Cr	₹145 Cr	₹138 Cr	₹79 Cr	₹169 Cr	₹93 Cr	₹85 Cr	-₹12 Cr	₹56 Cr	₹325 Cr	₹158 Cr	₹46 Cr	₹75 Cr	₹45 Cr	₹46 Cr	₹0
₹139 Cr	₹106 Cr	₹103 Cr	₹34 Cr	₹135 Cr	₹64 Cr	₹47 Cr	₹40 Cr	₹18 Cr	₹289 Cr	₹113 Cr	₹38 Cr	₹41 Cr	₹7 Cr	₹35 Cr	₹0
-₹38 Cr	-₹76 Cr	-₹83 Cr	-₹8 Cr	-₹93 Cr	-₹47 Cr	-₹48 Cr	-₹74 Cr	₹50 Cr	-₹231 Cr	-₹50 Cr	-₹29 Cr	-₹11 Cr	-₹124 Cr	-₹22 Cr	₹0
-₹89 Cr	-₹30 Cr	-₹21 Cr	-₹25 Cr	-₹24 Cr	-₹21 Cr	-₹6 Cr	₹17 Cr	-₹76 Cr	-₹10 Cr	-₹40 Cr	-₹42 Cr	-₹8 Cr	₹110 Cr	₹26 Cr	₹0
₹11 Cr	₹13 L	-₹1 Cr	₹2 Cr	₹19 Cr	-₹4 Cr	-₹7 Cr	-₹17 Cr	-₹8 Cr	₹48 Cr	₹23 Cr	-₹33 Cr	₹22 Cr	-₹8 Cr	₹40 Cr	₹0
₹24 Cr	₹24 Cr	₹25 Cr	₹22 Cr	₹13 Cr	₹15 Cr	₹15 Cr	₹37 Cr	₹47 Cr	₹0	₹5 Cr	₹39 Cr	₹28 Cr	₹58 Cr	₹18 Cr	₹0
₹0	₹0	₹0	₹0	₹0	₹0	₹5 L	₹0	₹0	₹17 Cr	₹0	₹0	₹0	₹0	₹0	₹0
₹10 L	₹10 L	-₹15 L	₹1 Cr	-₹10 Cr	₹2 Cr	₹8 Cr	-₹5 Cr	-₹2 Cr	-₹18 Cr	-₹34 L	-₹53 L	₹0	₹0	₹0	₹0
₹35 Cr	₹24 Cr	₹24 Cr	₹25 Cr	₹22 Cr	₹13 Cr	₹15 Cr	₹15 Cr	₹37 Cr	₹47 Cr	₹28 Cr	₹5 Cr	₹50 Cr	₹50 Cr	₹58 Cr	₹0

Fundamental Ratios

Consolidated

Standalone

No results found

Bliss GVS Pharma Share Price

692.00+27.20 (+4.09%)

+357.13% past 1 Year

Technical meters

Oscillators

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 6

Bearish signals: 0 out of 9 oscillators

RSI

55.88Buy

STOCH %K

46.27Neutral

MACD Level(12,26)

23.22Buy

Ultimate Oscillator

53.08Buy

Aroon Oscillator

84.00Buy

BOP

0.60Buy

CCI

-62.47Neutral

Williams %R

-53.73Neutral

Momentum

7.05Buy

Moving averages

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 6

Bearish signals: 3 out of 9 moving averages

EMA 9

690.62Buy

SMA 9

697.15Sell

EMA 21

676.14Buy

SMA 21

693.68Sell

EMA 50

616.66Buy

SMA 50

599.10Buy

EMA 200

419.37Buy

SMA 200

365.62Buy

WMA 20

693.43Sell

Pivot

Classic

Resistance 5

825.83

Resistance 4

787.93

Resistance 3

750.03

Resistance 2

712.13

Resistance 1

688.47

Pivot

674.23

Support 1

650.57

Support 2

636.33

Support 3

598.43

Support 4

560.53

Support 5

522.63

High & lows

1 Day

1 Week

1 Month

3 Months

6 Months

Year to Date

1 Year

3 Years

5 Years

10 Years

All Time

Low

660.00

650.75

443.00

248.50

152.26

118.00

77.35

66.10

18.80

High

697.00

697.90

739.90

Returns

+27.20

+8.40

+21.00

+179.05

+437.93

+528.61

+540.62

+603.30

+581.80

+548.50

+650.05

Beta

—

Std. deviation %

—

Open a free Demat account in minutes to start investing and screening .

Bliss GVS Pharma Share Price

692.00+27.20 (+4.09%)

+357.13% past 1 Year

Shareholding summary

Promoters

35.01%

FII

8.07%

DII

9.06%

0.26%

Others

47.6%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
35.01%	35.36%	35.36%	35.39%	35.44%	35.29%
8.07%	10.45%	14.54%	13.27%	12.65%	13.18%
9.06%	5.04%	5.78%	5.98%	6.54%	6.55%
0.26%	0.00%	0.00%	0.00%	0.00%	0.00%
47.60%	49.15%	44.32%	45.36%	45.37%	44.98%

Bulk & block deals

Name

Anupam Rasayan India Limited

Nova Vida Limited

Arian Investment Ltd

Nova Vida Limited

Arian Investment Ltd

Mateus Ltd

Arian Investment Ltd

Mateus Ltd

Arian Investment Ltd

Hrti Private Limited

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
28 Sep 2026	Purchase	162.74 Cr	₹723.29	22.50 L	Bulk	2.116044	NSE
21 Jul 2026	Purchase	33.95 Cr	₹485	7 L	Bulk	0.658325	NSE
21 Jul 2026	Sell	33.95 Cr	₹485	7 L	Bulk	0.658325	NSE
21 Jul 2026	Purchase	33.95 Cr	₹485	7 L	Block	0.658325	NSE
21 Jul 2026	Sell	33.95 Cr	₹485	7 L	Block	0.658325	NSE
29 Jun 2026	Purchase	56.35 Cr	₹490	11.50 L	Bulk	1.081534	NSE
29 Jun 2026	Sell	56.35 Cr	₹490	11.50 L	Bulk	1.081534	NSE
29 Jun 2026	Purchase	56.35 Cr	₹490	11.50 L	Block	1.081534	NSE
29 Jun 2026	Sell	56.35 Cr	₹490	11.50 L	Block	1.081534	NSE
29 May 2026	Purchase	19.20 Cr	₹419.26	4.58 L	Bulk	0.430731	NSE

Insider trading & SAST

Client name

Mates Visa Consultancy Private Limited

Gulbarga Trading And Investment Private Limited

Narsimha Shibroor Kamath

Life Insurance Corporation Of India

Clarus Capital I & Others

Gagan Harsh Sharma & Pacs

Punita Sharma & Pacs

Mr. Gagan Harsh Sharma

Mrs. Punita Sharma

Mr. Gagan Harsh Sharma

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
30 Sep 2026	Other	Acquisition	30.52	30.52	0	—	3.24 Cr	29 Sep 2026	Acquisition of shares - offmarket	3,24,37,224	SAST	29(1)	Equity Shares
30 Sep 2026	Other	Disposal	5.49	0	0	—	58.32 L	29 Sep 2026	Sale of Shares - offmarket	0	SAST	29(2)	Equity Shares
30 Sep 2026	Promoter	Disposal	30.52	0	0	—	3.24 Cr	29 Sep 2026	Sale of Shares - offmarket	0	SAST	29(2)	Equity Shares
24 Aug 2026	Other	Disposal	2.15	2.95	0	—	21.32 L	09 Sep 2020 - 10 Aug 2026	Market	31,44,284	SAST	29(2)	—
31 Jul 2026	Other	Acquisition	0.17	5.13	0	—	1.85 L	20 Jul 2026	Market	54,38,523	SAST	29(1)	—
17 Jun 2026	Promoter	Disposal	0.21	—	0	—	2.17 L	18 May 2026	Market	—	SAST	29(2)	—
27 May 2026	Promoter	Disposal	0.02	—	0	—	24.96 K	18 May 2026	Market	—	SAST	29(2)	—
21 May 2026	Promoter	Disposal	0.205242	0	6.20 Cr	₹285.78	2.17 L	18 May 2026	Market Sale	0	Insider Trading	—	Equity Shares
21 May 2026	Promoter Group	Disposal	0.023596	0	71.14 L	₹285	24.96 K	18 May 2026	Market Sale	0	Insider Trading	—	Equity Shares
23 Dec 2025	Promoter	Acquisition	0.002007	0.2	2.99 L	₹140.94	2.12 K	16 Dec 2025	Market Purchase	2,17,123	Insider Trading	—	Equity Shares

Bliss GVS Pharma Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Bliss GVS Pharma Share Price

Bliss GVS Pharma Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Bliss GVS Pharma Share Price

Bliss GVS Pharma Share Price

Oscillators

Moving averages

Bliss GVS Pharma Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Bliss GVS Pharma Share Price

Corporate Actions

Company details

Bliss GVS Pharma Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Bliss GVS Pharma Share Price

News

Bliss GVS Pharma Reports Rs 136.70 Crores NSE Block Trade

Bliss GVS Pharma informs about open offer

Bliss GVS Pharma rises on securing Inspection Closure Report from WHO

Bliss GVS Pharma gains WHO GMP compliance approval for Palghar facility

Bliss GVS Pharma informs about disclosure

Bliss GVS Pharma Q4 Consolidated Net Profit Rises to Rs 35.50 Crores, Up from Rs 15.50 Crores YoY

Bliss GVS Pharma Reports Q4 Revenue Growth to Rs 257 Crores, Up from Rs 198 Crores YoY

Bliss GVS Pharma Reports Strong Q4 EBITDA Growth to Rs 44.40 Crores, Margin Expands to 17.3%

Bliss GVS Pharma reports Profit after tax of 32.42 Crores, in the March 2026 quarter

Bliss GVS Pharma informs about credit rating

Bliss GVS Pharma informs about trading window closure

Bliss GVS Pharma Addresses Rumors of Acquiring Anupam Rasayan, No Official Decision Yet.

Anupam Rasayan May Acquire Stake in Bliss GVS Pharma as per CNBC Aawaz Report.

Bliss GVS Pharma - Quaterly Results

Bliss GVS Pharma Reports Strong Q3 EBITDA Growth of 16% YoY to Rs 34.80 Crores.

Bliss GVS Pharma Reports Q3 Revenue Growth to Rs 220 Crores, Up from Rs 210 Crores YoY.

Bliss GVS Pharma Q3 FY26 Net Profit Declines YoY to Rs 23.30 Crores

Bliss GVS Pharma reports Profit after tax of 18.61 Crores, in the December 2025 quarter

Bliss GVS Pharma Establishes Wholly Owned Subsidiary in Democratic Republic of Congo

Bliss GVS Pharma’s arm incorporates wholly owned subsidiary in Kenya

Bliss GVS Pharma Ltd Share Price Today

Bliss GVS Pharma Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator